The ambitious role of anti angiogenesis molecules: Turning a cold tumor into a hot one

Area of Science:

• Oncology
• Immunotherapy
• Cancer Treatment

Background:

• Renal cancer treatment landscape is evolving with new therapeutic options.
• There is a critical need to integrate novel therapies into clinical practice for better patient outcomes.
• Current treatment strategies may benefit from reformulation to incorporate emerging options.

Purpose of the Study:

• To highlight the necessity of combining therapies in renal cancer.
• To discuss the potential of leveraging common immune targets for combined strategies.
• To advocate for the redesign of clinical practice based on combined treatment approaches.

Main Methods:

• Review and discussion of current and emerging renal cancer treatment options.
• Analysis of common immune targets in renal cancer.
• Conceptual framework for designing combined immunotherapeutic strategies.

Main Results:

• Identification of shared immune targets across different renal cancer therapies.
• Potential for synergistic effects when combining therapies that target common immune pathways.
• Proposed strategies for integrating combined therapies into clinical practice.

Conclusions:

• Combined therapeutic strategies targeting common immune mechanisms are crucial for advancing renal cancer treatment.
• Exploiting shared immune targets offers a promising avenue to enhance clinical responses in renal cancer patients.
• A shift towards combination immunotherapy is needed to reformulate and improve current clinical practice for renal cancer.